✦ LIBER ✦

45 ORAL “N-ratio” as a novel prognostic factor for patients with stage III cutaneous melanoma

✍ Scribed by C.R. Rossi; S. Mocellin; L.G. Campana; S. Pasquali; M. Foletto; M. Lise; D. Nitti

Book ID: 117568641
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 63 KB
Volume: 32
Category: Article
ISSN: 0748-7983
DOI: 10.1016/s0748-7983(06)70480-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

N-Ratio: a Novel Independent Prognostic

N-Ratio: a Novel Independent Prognostic Factor for Patients with Stage-III Cutaneous Melanoma

✍ Carlo Riccardo Rossi; Simone Mocellin; Sandro Pasquali; Pierluigi Pilati; Donato 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 259 KB

Sarcopenia as a Prognostic Factor among

Sarcopenia as a Prognostic Factor among Patients with Stage III Melanoma

✍ Michael S. Sabel; Jay Lee; Shijie Cai; Michael J. Englesbe; Stephen Holcombe; St 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 413 KB

Lymph node ratio is an important and ind

Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma

✍ Adam C. Berger; Michael Fierro; John C. Kairys; David Berd; Takami Sato; Jocelyn 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

QS333. Lymph Node Ratio Is an Important

QS333. Lymph Node Ratio Is an Important and Independent Prognostic Factor for Patients With Stage III Malignant Melanoma

✍ M. Fierro; J.C. Kairys; M.J. Mastrangelo; D. Berd; T. Sato; E. Pequignot; T. Hys 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Tumor-derived interleukin-10 as a progno

Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine

✍ Amit Mahipal; Mizue Terai; David Berd; Inna Chervoneva; Kashyap Patel; Michael J 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 217 KB

Adjuvant high-dose interferon for cutane

Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients with early stage III disease

✍ Daniel A. Anaya; Yan Xing; Lei Feng; Xuelin Huang; Luis H. Camacho; Merrick I. R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## Abstract ## BACKGROUND. Evidence from randomized trials in the pre‐sentinel lymph node biopsy era indicate that adjuvant treatment with high‐dose interferon‐α (IFN) increases recurrence‐free survival (RFS) in patients with high‐risk melanoma. However, to the authors' knowledge, the role of this